🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objectives of this study are to determine the safety and effica...
Status
Completed
Location
UC San Diego-Moores Cancer Center
Start Date
2016-03-07
Trial ID
NCT02614066
Treatments Being Tested
The goal of this clinical study is to learn more about the long-term safety...
Status
Enrolling By Invitation
Location
Banner MD Anderson Cancer Center
Start Date
2021-12-15
Trial ID
NCT05041309
This phase II trial tests the effect of nemtabrutinib in combination with b...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2026-07-31
Trial ID
NCT07673367
Treatments Being Tested
To assess the feasibility of oral dasatinib pulses (3 consecutive days per ...
Status
Active Not Recruiting
Location
Stanford University
Start Date
2023-10-02
Trial ID
NCT05993949
Treatments Being Tested
First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Status
Recruiting
Location
University Hospital of Mainz
Start Date
2024-02-15
Trial ID
NCT06482684
Master protocol: The goal of this master clinical study is to test how well...
Status
Terminated
Location
City of Hope (City of Hope National Medical Center)
Start Date
2022-11-01
Trial ID
NCT05537766
Treatments Being Tested
To learn if the combination of axicabtagene ciloleucel (axi-cel) and glofit...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-05-07
Trial ID
NCT06213311
Treatments Being Tested
The goal of this clinical study is to learn more about KTE-X19, and how saf...
Status
Active Not Recruiting
Location
Chiba University Hospital
Start Date
2024-03-18
Trial ID
NCT06253663
Treatments Being Tested
Recently chimeric antigen receptor (CAR) T-cell therapy, a new class of che...
Status
Unknown
Location
University Hospital Bonn
Start Date
2022-05-16
Trial ID
NCT05414162
Treatments Being Tested
To learn about the safety of giving the drug brexucabtagene autoleucel to p...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-07-11
Trial ID
NCT06287229
Treatments Being Tested